Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Omnicef vs. Levofloxacin for Acute Bacterial Sinusitis
NCT00645073Phase 4Completed
- Sponsor
- Abbott Laboratories
- Start
- Nov 2003
- Primary completion
- Mar 2004
- Modality
- Reversible Covalent Inhibitors
- Countries
- 2
01
Overview
A Phase 4 trial of cefdinir in acute bacterial sinusitis (ABS), sponsored by Abbott Laboratories. Started Nov 2003; status: completed.
02
Drugs
cefdinir
03
Conditions
acute bacterial sinusitis (ABS)
Beyond the preview
Go deeper on NCT00645073.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00645073.